Factors Guiding Treatment Selection in Generalized Myasthenia Gravis

Key Takeaways

• Cancer type, stage, and molecular profile are pivotal in guiding targeted therapy decisions, ensuring precision in treatment selection.
• Patient-specific factors, including age, performance status, and comorbidities, significantly influence the tailoring of treatment plans.
• Consideration of potential side effects and patient tolerance is crucial in optimizing therapeutic outcomes and minimizing adverse effects.
• Personal preferences of patients are integral to the decision-making process, ensuring a personalized approach to treatment.